Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-026890

Chief Financial Officer sold 697 shares at $11.75 ($8,190)

  • Chief Financial Officer acquired 2,886 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

van Houte Hans · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-04-30 Exercise or conversion : show line 1 in the form +2,886 2,886 D
2022-05-02 Sale : show line 2 in the form −697 $11.75 $8,190 2,189 D
Open-market sales · 697 sh · avg $11.75 · $8,190

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,886 43,291 D
Loading xslF345X03/doc4.xml…